Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine zipper tumor suppressor family member 3 (LZTS3) is a protein believed to play a role in cellular growth modulation and neuronal synapse assembly. It is a member of the LZTS family, which includes other potential tumor suppressors. LZTS3 is encoded on chromosome 20p13 and is highly conserved among vertebrates. The protein contains a leucine zipper motif and is predicted to localize in the nucleus and postsynaptic density of neurons, with highest expression in the brain and kidney. Its precise physiological functions remain under investigation, but predictions and limited experimental evidence suggest roles in dendritic spine maturation and possibly in regulating mitosis, similar to other LZTS proteins. Although LZTS family members have been implicated in cancer biology, specific links between LZTS3 and human disease remain largely predictive or inferred from family association[1][2][3][8].
no drugs known; mechanism of action not established for therapeutic targeting
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine zipper tumor suppressor family member 3 (LZTS3).